| Hospice And Palliative Care 200 Mill Road, Fairhaven, MA, 02719 | |
| (508) 973-3200 |
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| Name | Hospice And Palliative Care |
|---|---|
| Location | 200 Mill Road, Fairhaven, Massachusetts |
| Hospice ID | 221536 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 020 |
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| NPI Number | 1013931500 |
| Organization Name | Southcoast Hospitals Group, Inc |
| Address | 200 Mill Rd Fairhaven, Massachusetts, 02719 |
| Phone Number | (508)984-0200 |
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.6 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.4 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 99.7 | 93.3 |
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| Home Health Aides | 6.4 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 4 |
| Physicians | 0.5 |
| Registered Nurses | 22.4 |
| Other Personnel | 7 |
| Total Employees | 43.3 |
|---|
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| Others | 19.9 |
| Total Volunteers | 19.9 |
|---|
News Archive
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.
Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 1 days ago
| Hospice And Palliative Care Location: 200 Mill Road, Fairhaven, Massachusetts, 02719 Phone: (508) 973-3200 |
| Community Nurse Home Care, Inc Location: 62 Center Street, Fairhaven, Massachusetts, 02719 Phone: (508) 973-3200 |